UBS Group’s Ocean Bio-Chem Inc OBCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,560
| Closed | -$136K | – | 11763 |
|
|
2022
Q2 | $136K | Buy |
+10,560
| New | +$83.8K | ﹤0.01% | 5201 |
|
|
2021
Q4 | – | Sell |
-564
| Closed | -$5K | – | 11192 |
|
|
2021
Q3 | $5K | Buy |
564
+284
| +101% | +$2.99K | ﹤0.01% | 8598 |
|
|
2021
Q2 | $3K | Sell |
280
-933
| -77% | -$11.9K | ﹤0.01% | 8898 |
|
|
2021
Q1 | $15K | Buy |
+1,213
| New | +$14.6K | ﹤0.01% | 7655 |
|
|
2020
Q4 | – | Sell |
-849
| Closed | -$12K | – | 8965 |
|
|
2020
Q3 | $12K | Buy |
849
+493
| +138% | +$7.46K | ﹤0.01% | 6728 |
|
|
2020
Q2 | $5K | Sell |
356
-375
| -51% | -$2.5K | ﹤0.01% | 7406 |
|
|
2020
Q1 | $4K | Sell |
731
-2
| -0.3% | -$8 | ﹤0.01% | 7438 |
|
|
2019
Q4 | $2K | Buy |
+733
| New | +$2.5K | ﹤0.01% | 7886 |
|
|
2019
Q2 | – | Sell |
-2,301
| Closed | -$8K | – | 8303 |
|
|
2019
Q1 | $8K | Buy |
+2,301
| New | +$8.37K | ﹤0.01% | 6969 |
|
|
2017
Q4 | – | Sell |
-239
| Closed | -$1K | – | 8209 |
|
|
2017
Q3 | $1K | Sell |
239
-2,374
| -91% | -$10.2K | ﹤0.01% | 7614 |
|
|
2017
Q2 | $10K | Buy |
2,613
+2,313
| +771% | +$10.3K | ﹤0.01% | 6795 |
|
|
2017
Q1 | $1K | Sell |
300
-8,087
| -96% | -$34.4K | ﹤0.01% | 7494 |
|
|
2016
Q4 | $31K | Buy |
8,387
+4,486
| +115% | +$14.8K | ﹤0.01% | 6218 |
|
|
2016
Q3 | $11K | Buy |
3,901
+3,601
| +1,200% | +$8.91K | ﹤0.01% | 6739 |
|
|
2016
Q2 | $1K | Sell |
300
-883
| -75% | -$2.06K | ﹤0.01% | 7592 |
|
|
2016
Q1 | $3K | Sell |
1,183
-1,797
| -60% | -$3.94K | ﹤0.01% | 7229 |
|
|
2015
Q4 | $7K | Buy |
2,980
+1,299
| +77% | +$3.27K | ﹤0.01% | 7543 |
|
|
2015
Q3 | $5K | Buy |
1,681
+737
| +78% | +$2.18K | ﹤0.01% | 7748 |
|
|
2015
Q2 | $3K | Buy |
944
+644
| +215% | +$2.46K | ﹤0.01% | 8101 |
|
|
2015
Q1 | $1K | Sell |
300
-961
| -76% | -$4.61K | ﹤0.01% | 8608 |
|
|
2014
Q4 | $5K | Buy |
+1,261
| New | +$4.88K | ﹤0.01% | 9016 |
|
UBS Group's OBCI Position: Q3 2022 in Review
UBS Group sold out of Ocean Bio-Chem Inc (OBCI) in Q3 2022, closing a stake of 10,560 shares — an estimated $136K sold.
UBS Group first reported a position in OBCI in Q4 2014 and held it in 21 quarters. The position peaked at $136K in Q2 2022. 0 funds tracked by Wall St. Rank hold OBCI as of Q3 2022.
- UBS Group reported no remaining Ocean Bio-Chem Inc position as of Q3 2022 after selling out during the quarter.
- UBS Group sold 10,560 Ocean Bio-Chem Inc shares in Q3 2022, an estimated $136K.
- UBS Group first reported a position in Ocean Bio-Chem Inc in Q4 2014 and held it in 21 quarters.
- UBS Group's Ocean Bio-Chem Inc position peaked at $136K in Q2 2022.
- 0 funds tracked by Wall St. Rank held Ocean Bio-Chem Inc as of Q3 2022.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.